跳至主要内容
临床试验/NCT03235492
NCT03235492撤回不适用

Clinical Study of Salivary Glycated Albumin

University of Maryland, Baltimore2 个研究点 分布在 1 个国家开始时间: 2017年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Salivary glycated albumin vs. glycosylated hemoglobin (HbA1c)

研究概览

简要总结

(1) to determine whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood and (2) to investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure glycosylated hemoglobin (HbA1c).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 123 individuals with type 1 or type 2 diabetes
  • 53 non diabetic controls
  • Age: 18 to 80
  • Body mass index >18.5kg / m2

排除标准

  • Acute illness (within 7 days) - respiratory infection, fever above 38 °C, sinusitis infection, severe allergies.
  • Individuals with known sickle cell, pregnancy, hemoglobinopathies, renal failure
  • Subjects unable to give voluntary informed consent

结局指标

主要结局

Salivary glycated albumin vs. glycosylated hemoglobin (HbA1c)

时间窗: 30 min

To investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure HbA1c.

Salivary glycated albumin vs. blood glycated albumin

时间窗: 30 min

Whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen N. Davis, MBBS

Chairman of Medicine

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验